hasTradeName

P24555
predicate

Indicates that a product, substance, or entity is known or marketed under a specific commercial or brand name.

Try in SPARQL

All labels observed (5)

Label Occurrences
hasTradeName canonical 53
hasMainTradeName 1
hasTrademarksAssociated 1

Description generation (PDg)

The one-sentence description above was generated by prompting gpt-5.1 with the predicate name and this instruction.

Instruction
Given a predicate that represents a relationship or action between entities, generate a one-sentence description explaining its meaning.  
# Instructions
Focus on describing the relationship, not the entities themselves. 
# Response Format
Begin the description with \' Indicates...\'
Input
Predicate: hasTradeName
Generated description
Indicates that a product, substance, or entity is known or marketed under a specific commercial or brand name.

Sample triples (57)

Subject Object
Plegridy Plegridy self-link ⓘ
Fampyra Fampyra self-link ⓘ
FMNH PR 2081 yes via predicate surface "hasTrademarksAssociated" ⓘ
onasemnogene abeparvovec onasemnogene abeparvovec self-linksurface differs ⓘ
surface form: Zolgensma
Primark Penneys via predicate surface "tradeNameInIreland" ⓘ
faricimab Vabysmo ⓘ
aflibercept Eylea ⓘ
aflibercept Zaltrap ⓘ
Persona knee system
surface form: Persona Knee System
Persona knee system self-link ⓘ
surface form: Persona Knee System
andexanet alfa Andexxa ⓘ
andexanet alfa Ondexxya ⓘ
apixaban apixaban self-linksurface differs ⓘ
surface form: Eliquis
bortezomib bortezomib self-linksurface differs ⓘ
surface form: Velcade
bortezomib Bortecad ⓘ
bortezomib bortezomib self-linksurface differs ⓘ
surface form: Bortezomib Accord
bortezomib bortezomib self-linksurface differs ⓘ
surface form: Bortezomib Teva
rimonabant Acomplia ⓘ
rimonabant Zimulti ⓘ
pertuzumab Perjeta ⓘ
velpatasvir
surface form: Velpatasvir
Epclusa ⓘ
Biktarvy Biktarvy self-link ⓘ
H2 receptor antagonist cimetidine
surface form: cimetidine
Tagamet NERFINISHED ⓘ
Keytruda Keytruda NERFINISHED ⓘ
Gardasil Silgard NERFINISHED ⓘ
ansuvimab Ebanga NERFINISHED ⓘ
Celebrex Celebrex NERFINISHED ⓘ
larotrectinib Vitrakvi NERFINISHED ⓘ
Tiglutik Tiglutik NERFINISHED ⓘ
inotersen Tegsedi NERFINISHED ⓘ
Kevzara Kevzara NERFINISHED ⓘ
Kymriah
surface form: tisagenlecleucel
Kymriah NERFINISHED ⓘ
Tasigna Tasigna NERFINISHED ⓘ
Alecensa Alecensa NERFINISHED ⓘ
avelumab Bavencio NERFINISHED ⓘ
nivolumab Opdivo NERFINISHED ⓘ
MEI
surface form: Matsushita Electric Industrial Co., Ltd.
Panasonic via predicate surface "hasMainTradeName" NERFINISHED ⓘ
Shell Transport and Trading Company Shell Transport and Trading Company plc via predicate surface "usedTradingName" NERFINISHED ⓘ
sulfasalazine Azulfidine NERFINISHED ⓘ
sulfasalazine Salazopyrin NERFINISHED ⓘ
Ondexxya Ondexxya NERFINISHED ⓘ
isatuximab Sarclisa NERFINISHED ⓘ
pomalidomide Pomalyst NERFINISHED ⓘ
pomalidomide Imnovid NERFINISHED ⓘ
Ofatumumab Arzerra NERFINISHED ⓘ
Ofatumumab Kesimpta NERFINISHED ⓘ
Teprotumumab Tepezza NERFINISHED ⓘ
idarucizumab Praxbind NERFINISHED ⓘ
acalabrutinib Calquence NERFINISHED ⓘ
pirtobrutinib Jaypirca NERFINISHED ⓘ
zanubrutinib Brukinsa NERFINISHED ⓘ